American Century Companies Inc Morphic Holding, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$26.12 - $34.07 $433,748 - $565,766
16,606 Added 254.38%
23,134 $788,000
Q1 2024

May 14, 2024
BUY
$26.64 - $40.31 $173,905 - $263,143
6,528 New
6,528 $229,000
Q2 2023

Aug 14, 2023
SELL
$34.33 - $62.11 $43,702 - $79,066
-1,273 Reduced 14.55%
7,479 $428,000
Q1 2023

May 11, 2023
BUY
$26.01 - $48.69 $227,639 - $426,134
8,752 New
8,752 $329,000

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email